The Moderna laboratory categorically refuses to submit to the request of the Chinese authorities to reveal to them the technology used to manufacture its vaccine against Covid-19
The American pharmaceutical giant Moderna categorically refuses to reveal to the Chinese authorities the technology behind its ARM anti-Covid vaccine. At least that’s the information Lecourrier-du-soir.com obtained, on October 02, from several reliable sources including the press agency Reuters.
Indeed, according to this media which quotes the FinancialTimes, the American laboratory, headquartered in Massachusetts, raises concerns related to security. According to the same source, the laboratory is however open to collaborating with the Chinese authorities so that its vaccine is used in this country.
“We would be happy to work with China if the authorities in that country feel the need to bring vaccines to that country. Currently, there is no activity in progress, but we are open to any proposal”, let know Paul Burton, one of the most important personalities of Moderna.
The information was confirmed by the media AsiaFinancial.com. Indeed, according to this source, it was the Chinese authorities who had required the American laboratory to provide data concerning the technology used to manufacture its vaccine against Covid before its use in China. For the moment, Moderna says niet.
The news sparked a wave of reactions on social media.
Moderna refused China request to reveal vaccine technology because of Beijing’s demand that it hand over the technology as a prerequisite for selling into the country. (Remember when it all started in Wuhan, China refused sharing the genome of the virus). https://t.co/MZUWGqTJMk
— Sari Arho Havren (@SariArhoHavren) October 2, 2022
“Moderna has refused to hand over to #China the core intellectual property behind the development of its breakthrough Covid-19 vaccine, leading to a collapse in negotiations on its sale there, according to multiple people familiar with the matter.” https://t.co/YorwjTbF50
—William Yang (@WilliamYang120) October 2, 2022
The mRNA tech of Pfizer/Moderna is superior over China’s two inactivated-virus vaccines. Beijing’s refusal to grant market access, is bad policy. Even if its own mRNA vaccine was rolled out today, achieving immunity won’t occur until mid-2023.
Zero-Covid lingers on and on. https://t.co/gc4fcpYiTT
—James M Zimmerman (@jmzbeijing) October 2, 2022